Sun H - Search Results

1

Polymorphisms in IGF2/H19 gene locus are associated with platinum-based chemotherapeutic response in Chinese patients with epithelial ovarian cancer.

Zeng Y, Li TL, Zhang HB, Deng JL, Zhang R, Sun H, Wan ZR, Liu YZ, Zhu YS, Wang G. Zeng Y, et al. Among authors: sun h. Pharmacogenomics. 2019 Feb;20(3):179-188. doi: 10.2217/pgs-2018-0153. Epub 2019 Jan 23. Pharmacogenomics. 2019. PMID: 30672383

2

The association of adiponectin allele 45T/G and -11377C/G polymorphisms with Type 2 diabetes and rosiglitazone response in Chinese patients.

Sun H, Gong ZC, Yin JY, Liu HL, Liu YZ, Guo ZW, Zhou HH, Wu J, Liu ZQ. Sun H, et al. Br J Clin Pharmacol. 2008 Jun;65(6):917-26. doi: 10.1111/j.1365-2125.2008.03145.x. Epub 2008 Apr 22. Br J Clin Pharmacol. 2008. PMID: 18429970 Free PMC article.

3

Impact of genetic polymorphisms of leptin and TNF-alpha on rosiglitazone response in Chinese patients with type 2 diabetes.

Liu HL, Lin YG, Wu J, Sun H, Gong ZC, Hu PC, Yin JY, Zhang W, Wang D, Zhou HH, Liu ZQ. Liu HL, et al. Among authors: sun h. Eur J Clin Pharmacol. 2008 Jul;64(7):663-71. doi: 10.1007/s00228-008-0483-9. Epub 2008 Apr 26. Eur J Clin Pharmacol. 2008. PMID: 18438653

4

H19 lncRNA mediates 17β-estradiol-induced cell proliferation in MCF-7 breast cancer cells.

Sun H, Wang G, Peng Y, Zeng Y, Zhu QN, Li TL, Cai JQ, Zhou HH, Zhu YS. Sun H, et al. Oncol Rep. 2015 Jun;33(6):3045-52. doi: 10.3892/or.2015.3899. Epub 2015 Apr 3. Oncol Rep. 2015. PMID: 25846769

5

Marked Alteration of Rosuvastatin Pharmacokinetics in Healthy Chinese with ABCG2 34G>A and 421C>A Homozygote or Compound Heterozygote.

Wan Z, Wang G, Li T, Xu B, Pei Q, Peng Y, Sun H, Cheng L, Zeng Y, Yang G, Zhu YS. Wan Z, et al. Among authors: sun h. J Pharmacol Exp Ther. 2015 Sep;354(3):310-5. doi: 10.1124/jpet.115.225045. Epub 2015 Jun 16. J Pharmacol Exp Ther. 2015. PMID: 26081159

6

URAT1 gene polymorphisms influence uricosuric action of losartan in hypertensive patients with hyperuricemia.

Sun H, Qu Q, Qu J, Lou XY, Peng Y, Zeng Y, Wang G. Sun H, et al. Pharmacogenomics. 2015 Jul;16(8):855-63. doi: 10.2217/pgs.15.52. Epub 2015 Jun 18. Pharmacogenomics. 2015. PMID: 26086348 Free article.

7

Analysis of ABCG2 methylation in stool samples of Chinese healthy males by pyrosequencing.

Peng Y, Xu B, Tang J, Wan Z, Sun H, Wang G, Zhu YS. Peng Y, et al. Among authors: sun h. Pharmazie. 2016 Aug 1;71(8):447-454. doi: 10.1691/ph.2016.6559. Pharmazie. 2016. PMID: 29442031

8

Cost-effectiveness analysis of UGT1A1*6/*28 genotyping for preventing FOLFIRI-induced severe neutropenia in Chinese colorectal cancer patients.

Wei X, Cai J, Sun H, Li N, Xu C, Zhang G, Sui Y, Zhuang J, Zheng B. Wei X, et al. Among authors: sun h. Pharmacogenomics. 2019 Mar;20(4):241-249. doi: 10.2217/pgs-2018-0138. Epub 2019 Jan 10. Pharmacogenomics. 2019. PMID: 30628534

9

LncRNA Profile Study Reveals a Three-LncRNA Signature Associated With the Pathological Complete Response Following Neoadjuvant Chemotherapy in Breast Cancer.

Zeng Y, Wang G, Zhou CF, Zhang HB, Sun H, Zhang W, Zhou HH, Liu R, Zhu YS. Zeng Y, et al. Among authors: sun h. Front Pharmacol. 2019 May 28;10:574. doi: 10.3389/fphar.2019.00574. eCollection 2019. Front Pharmacol. 2019. PMID: 31191314 Free PMC article.

10

CYP2D6*10 pharmacogenetic-guided SERM could be a cost-effective strategy in Chinese patients with hormone receptor-positive breast cancer.

Wei X, Cai J, Zhuang J, Zheng B, Sui Y, Zhang G, Lin Y, Sun H. Wei X, et al. Among authors: sun h. Pharmacogenomics. 2020 Jan;21(1):43-53. doi: 10.2217/pgs-2019-0073. Epub 2019 Nov 26. Pharmacogenomics. 2020. PMID: 31769341

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

32,314 results

Search Page

Filters